Trepanostika TP recombinant 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BioMerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-03-08
  • 사례 출판 날짜
    2013-03-08
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomerieux trepanostika tp recombinant medical device manufacturer, biomerieux, inc., has initiated a medical device field safety correction action concerning trepanostika tp recombinant with reference no.: 285034 and 285035. the affected lot numbers are d33ga, d33ha, d33ka, d33kb, d33kc, d33ma, d33n. following customer complaints on negative control out of range, biomerieux investigation has confirmed an issue with some lots of trepanostika tp recombinant and that the problem is due to the aluminum bag that contains the microelisa strip plates. the impacted strips may contain bad aluminum bags, or a mixture of good and bag aluminum bags. as a result, customers may either experience false results or negative control out of range. the investigation also determined that the 2 lots d33ma and d33na also show a reduced sensitivity which may lead to obtain false nonreactive results. the risk is considered as critical because false nonreactive results could lead to a non-reversible injury or illness to an individual or patient that requires immediate and/or major professional medical intervention. the manufacturer advises users stop using and discard the affected product that they may have in stock. also, the manufacturer advises users that for samples previously tested with the lots d33ka, d33kb, d33kc retest the samples having results with a ratio between 0.7 and 1.3. and for samples previously tested with the lots d33ma and d33na retest all the nonreactive samples. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 8 march 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BioMerieux Trepanostika TP recombinant
  • Manufacturer

Manufacturer